MEDICLINIC INTERNATIONAL PLC - Appointment of Joint Corporate Broker

Appointment of Joint Corporate Broker

Mediclinic International plc 
(Incorporated in England and Wales) 
Company Number: 08338604 
LSE Share Code: MDC 
JSE Share Code: MEI 
NSX Share Code: MEP 
ISIN: GB00B8HX8Z88 
LEI: 2138002S5BSBIZTD5I60 
(“Mediclinic”, the “Company” or the “Group”) 
 
15 May 2018 
                                                 
Appointment of Joint Corporate Broker 
                                                 
Mediclinic International plc, the international private healthcare services group, is pleased to 
announce the appointment of UBS as joint corporate broker to the Company. UBS will work 
alongside Morgan Stanley, the Company’s existing corporate broker. 
 
For further information, please contact:  
 
Investor Relations, Mediclinic International plc 
James Arnold, Head of Investor Relations 
ir@mediclinic.com  
+44 (0)203 786 8181 
 
Morgan Stanley & Co International plc  
Tom Perry 
+44 (0)207 425 8000 
 
UBS Investment Bank 
David James 
Thomas Raynsford 
+44 (0)207 567 8000 
 
Media queries 
FTI Consulting  
Brett Pollard/Debbie Scott – UK 
+44 (0)203 727 1000  
Sherryn Schooling – South Africa  
+27 (0)21 487 9000  
 
Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom 
Website: www.mediclinic.com 

                                                                                                 
 
JSE sponsor (South Africa): Rand Merchant Bank (A division of FirstRand Bank Limited) 
NSX sponsor (Namibia): Simonis Storm Securities (Pty) Ltd 
 
About Mediclinic International plc 
Mediclinic is an international private healthcare services group, established in South Africa in 
1983, with current operating divisions in Southern Africa (South Africa and Namibia), 
Switzerland and the United Arab Emirates. Its core purpose is to enhance the quality of life of 
patients by providing acute care, specialist-orientated, multi-disciplinary healthcare services. 
Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a LSE listed and UK-based 
private healthcare group.  
 
Mediclinic comprises 75 hospitals and 28 clinics. Hirslanden operates 17 hospitals and 4 clinics 
in Switzerland with more than 1 800 inpatient beds; Mediclinic Southern Africa operates 49 
hospitals and 2 day clinics throughout South Africa and 3 hospitals in Namibia with more than 
8 100 inpatient beds in total; and Mediclinic Middle East operates 6 hospitals and 22 clinics 
with more than 700 inpatient beds in the United Arab Emirates.  
 
Mediclinic has a primary listing on the Main Market of the LSE in the United Kingdom, with 
secondary listings on the JSE in South Africa and the NSX in Namibia. 
 




                                                                                                 
 

Date: 15/05/2018 08:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.